This guide explains the key differences between GLP-1 therapies and Retatrutide and why researchers believe the next generation of metabolic peptides may transform medical weight management
The competitive race is only accelerating with next-generation GLP-1s, oral agents, combination incretins and muscle-preserving therapies advancing rapidly, today's leader could quickly become tomorrow's benchmark
Here, the food and beverage industry is prepared to capitalize
It's a common but often overlooked result of losing a vast amount of weight that can be devastating, medically and emotionally
The glucagon receptors known role in hepatic lipid handling makes this a mechanistically plausible avenue, and dedicated studies in this area are anticipated
By slowing gastric emptying and signaling satiety to the brain, they can cause side effects like nausea, vomiting, or diarrhea, especially when first introduced